Cargando…

ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases

ATP12A encodes the catalytic subunit of the non-gastric proton pump, which is expressed in many epithelial tissues and mediates the secretion of protons in exchange for potassium ions. In the airways, ATP12A-dependent proton secretion contributes to complex mechanisms regulating the composition and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dębczyński, Michał, Gorrieri, Giulia, Mojsak, Damian, Guida, Floriana, Zara, Federico, Scudieri, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605105/ https://www.ncbi.nlm.nih.gov/pubmed/37892136 http://dx.doi.org/10.3390/biom13101455

Ejemplares similares

SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease
por: Gorrieri, Giulia, et al.
Publicado: (2022)

Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Mojsak, Damian, et al.
Publicado: (2021)

A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin
por: Dębczyński, Michał, et al.
Publicado: (2022)

The Many Faces of Immune Checkpoint Inhibitor-Associated Pneumonitis: 4 Case Reports
por: Mojsak, Damian, et al.
Publicado: (2022)

Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis
por: Mojsak, Damian, et al.
Publicado: (2023)

Proton Pump Inhibitor Use Is Associated With an Increased Frequency of Hospitalization in Patients With Cystic Fibrosis
por: Ayoub, Fares, et al.
Publicado: (2017)

Acidification of endocytic vesicles by an ATP-dependent proton pump
Publicado: (1983)

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients
por: Pohl, John F., et al.
Publicado: (2011)

Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens
por: Scoffone, Viola Camilla, et al.
Publicado: (2021)

The lateral distance between a proton pump and ATP synthase determines the ATP-synthesis rate
por: Sjöholm, Johannes, et al.
Publicado: (2017)

Structural and Functional Diversity of Two ATP-Driven Plant Proton Pumps
por: Kabała, Katarzyna, et al.
Publicado: (2023)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Mechanism of ADP-Inhibited ATP Hydrolysis in Single Proton-Pumping F(o)F(1)-ATP Synthase Trapped in Solution
por: Pérez, Iván, et al.
Publicado: (2023)

Role of ATP binding and hydrolysis in the gating of the cystic fibrosis transmembrane conductance regulator
por: Gout, Taras
Publicado: (2012)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

Bimodal Action of Protons on ATP Currents of Rat PC12 Cells
por: Skorinkin, Andrei, et al.
Publicado: (2003)

Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
por: Otremba, Iwona, et al.
Publicado: (2016)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients
por: Schippa, Serena, et al.
Publicado: (2013)

Cystic Fibrosis Transmembrane Conductance Regulator–associated ATP Release Is Controlled by a Chloride Sensor
por: Jiang, Qinshi, et al.
Publicado: (1998)

Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients
por: Lahner, Edith, et al.
Publicado: (2017)

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients
por: Schippa, Serena, et al.
Publicado: (2013)

TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells
por: Petruzzelli, Raffaella, et al.
Publicado: (2022)

Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents
Publicado: (1992)

Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis
por: Bar-Yoseph, Ronen, et al.
Publicado: (2019)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
por: Ghebremariam, Yohannes T, et al.
Publicado: (2015)

A case of testicular atrophy associated with cystic fibrosis
por: Profka, Eriselda, et al.
Publicado: (2020)

Editorial: Genome Editing to Treat Cystic Fibrosis and Other Pulmonary Diseases
por: Vaidyanathan, S., et al.
Publicado: (2022)

Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
por: Bruno, Giovanni, et al.
Publicado: (2019)

Biophysical comparison of ATP-driven proton pumping mechanisms suggests a kinetic advantage for the rotary process depending on coupling ratio
por: Anandakrishnan, Ramu, et al.
Publicado: (2017)

Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease
por: Wagner, Claudius J., et al.
Publicado: (2016)

ATP and AMP Mutually Influence Their Interaction with the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) at Separate Binding Sites
por: Randak, Christoph O., et al.
Publicado: (2013)

Vitamin B(12) Deficiency Associated With Concomitant Metformin and Proton Pump Inhibitor Use
por: Long, Amanda N., et al.
Publicado: (2012)

Evaluation of Vitamin B12 Monitoring in Patients on Concomitant Metformin and Proton Pump Inhibitors
por: Chappell, Logan, et al.
Publicado: (2020)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Progress with proton pump inhibition.
por: Bell, N. J., et al.
Publicado: (1992)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4i55r7fnl4joem2am1386nht8u